FATE - Fate Therapeutics prices equity offering at $28.31 June, 09 2020 04:43 AM Fate Therapeutics Inc. Fate Therapeutics (NASDAQ:FATE) has priced its public offering of 6,181,562 common shares at $28.31/share, for an aggregate offering of ~$175M.More news on: Fate Therapeutics, Inc., Healthcare stocks news, , Read more ...